Increased MCL-1 expression predicts poor prognosis and disease recurrence in acute myeloid leukemia.

Abstract:

:Background: Altered expression of the BCL-2 family member MCL-1 has been linked to the progression and outcome of various malignancies. Recently, MCL-1 inhibitor S63845 was reported to kill MCL-1-dependent cancer cells and has potential value in clinical application. Purpose: Herein, we reported MCL-1 expression pattern in Chinese de novo acute myeloid leukemia (AML) and its impact on prognosis and may provide theoretical basis for AML patients using MCL-1 inhibitor in clinics. Real-time quantitative PCR was carried out to detect the transcript of MCL-1 in AML patients. Results:MCL-1 expression was significantly up-regulated in AML compared with controls (P=0.042). We divided the patients into two groups (higher and lower expression of MCL-1) based on the median level. Among both non-acute promyelocytic leukemia (APL) and cytogenetically normal AML (CN-AML), patients with higher expression of MCL-1 correlated with lower complete remission (CR) rate (P=0.031 and 0.004, respectively) and shorter overall survival (OS) time (P=0.008 and 0.004, respectively) compared with those with lower expression of MCL-1. Meanwhile, Cox regression analyses revealed that overexpression of MCL-1 acted as an independent risk factor for OS in non-APL patients and CN-AML patients (P=0.011 and 0.045, respectively). In follow-up patients, MCL-1 expression level decreased after CR compared with newly diagnosis time (P=0.020) and increased after relapse (P=0.004). Conclusion: Our findings suggest that higher expression of MCL-1 predicts poor prognosis and can be used for disease monitoring.

journal_name

Onco Targets Ther

journal_title

OncoTargets and therapy

authors

Li XX,Zhou JD,Wen XM,Zhang TJ,Wu DH,Deng ZQ,Zhang ZH,Lian XY,He PF,Yao XY,Lin J,Qian J

doi

10.2147/OTT.S194549

subject

Has Abstract

pub_date

2019-05-01 00:00:00

pages

3295-3304

issn

1178-6930

pii

194549

journal_volume

12

pub_type

杂志文章
  • Upregulation of SOX18 in colorectal cancer cells promotes proliferation and correlates with colorectal cancer risk.

    abstract:Background:Since colorectal cancer (CRC) is one of the most common malignant tumors worldwide, we aimed to identify the role of sex determining region Y (SRY)-box 18 (SOX18) in CRC. Methods:RT-PCR and immunohistochemistry were employed to detect the expression of SOX18 in CRC samples. We then identified the effect of ...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S178916

    authors: Miao Z,Deng X,Shuai P,Zeng J

    更新日期:2018-11-29 00:00:00

  • The NRF2/KEAP1 Pathway Modulates Nasopharyngeal Carcinoma Cell Radiosensitivity via ROS Elimination.

    abstract:Purpose:Radioresistance is a vital obstacle for the prognosis of human nasopharyngeal carcinoma (NPC), but the underlying mechanism is still unknown. Here, we explored the role of the NRF2/KEAP1 pathway in radioresistance of NPC cell lines. Materials and Methods:We selected NPC cell lines CNE-1 and CNE-2, treated them...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S260169

    authors: Zhou J,Ding J,Ma X,Zhang M,Huo Z,Yao Y,Li D,Wang Z

    更新日期:2020-09-11 00:00:00

  • Integrated bioinformatic analysis unveils significant genes and pathways in the pathogenesis of supratentorial primitive neuroectodermal tumor.

    abstract:Purpose:This study aimed to explore significant genes and pathways involved in the pathogenesis of supratentorial primitive neuroectodermal tumor (sPNET). Materials and methods:Gene expression profile of GSE14295 was downloaded from publicly available Gene Expression Omnibus (GEO) database. Differentially expressed ge...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S148776

    authors: Wang GY,Li L,Liu B,Han X,Wang CH,Wang JW

    更新日期:2018-04-04 00:00:00

  • GADD45a Mediated Cell Cycle Inhibition Is Regulated By P53 In Bladder Cancer.

    abstract:Background:Bladder cancer (BC) is one of the most prevalent malignancies of the genitourinary system, yet the underlying mechanism of BC progression still remains unclear. Growth arrest and DNA damage-inducible 45 alpha (GADD45a) is a repressive gene implicated in cell cycle regulation, as well as in human cancers deve...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S222223

    authors: Han N,Yuan F,Xian P,Liu N,Liu J,Zhang H,Zhang H,Yao K,Yuan G

    更新日期:2019-09-16 00:00:00

  • Impact of Programmed Death Ligand 1 Expression in Advanced Non-Small-Cell Lung Cancer Patients, Treated by Chemotherapy (GFPC 06-2015 Study).

    abstract:Background:Few data have been published on the clinical and histopathological characteristics of advanced non-small-cell lung cancer (NSCLC) patients with high PD-L1 expression versus intermediate or none and the prognostic value of PD-L1 expression for patients treated with chemotherapy is unknown. This study was unde...

    journal_title:OncoTargets and therapy

    pub_type: 临床试验

    doi:10.2147/OTT.S288825

    authors: Auliac JB,Guisier F,Bizieux A,Assouline P,Bernardini M,Lamy R,Justeau G,François G,Damotte D,Chouaïd C

    更新日期:2020-12-30 00:00:00

  • G-MDSCs-Derived Exosomal miRNA-143-3p Promotes Proliferation via Targeting of ITM2B in Lung Cancer.

    abstract:Background:The immune environment of lung cancer is complex, and the critical immune factors that promote lung cancer progression need to be explored. Granulocytic myeloid-derived suppressor cells (G-MDSCs) are regarded as immune suppressing cells. However, they also promote tumor progression through other ways, which ...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S256378

    authors: Zhou JH,Yao ZX,Zheng Z,Yang J,Wang R,Fu SJ,Pan XF,Liu ZH,Wu K

    更新日期:2020-09-30 00:00:00

  • Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study.

    abstract:BACKGROUND:The purpose of this study was to determine the efficacy of sorafenib in preventing and treating tumor recurrence after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria. METHODS:Thirty patients with primary hepatic carcinoma exceeding the Milan criteria underwent ...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S31387

    authors: Huang L,Li GM,Zhu JY,Li Z,Li T,Leng XS

    更新日期:2012-01-01 00:00:00

  • Combination of CpG Oligodeoxynucleotide and Anti-4-1BB Antibody in the Treatment of Multiple Hepatocellular Carcinoma in Mice.

    abstract:Background:To investigate the effect of topical application of CpG oligodeoxynucleotide (CpG-ODN) combined with anti-4-1BB antibodies on mouse HCC multiple tumor-bearing models and the degree of improvement of anti-tumor immune response in mice. Materials and Methods:We inoculated each BALB/c male mouse subcutaneously...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S260353

    authors: Ma S,Yang X,Zhou H,Zhang C,Kang J,Sun D

    更新日期:2020-07-20 00:00:00

  • Decreased expression levels of PIWIL1, PIWIL2, and PIWIL4 are associated with worse survival in renal cell carcinoma patients.

    abstract::Piwi-interacting RNAs (piRNAs) are a newly discovered class of small non-coding RNAs involved in silencing of transposable elements and in sequence-specific chromatin modifications. PIWI proteins (PIWIL), which belong to the family of Argonaute genes/proteins, bind to piRNAs and function mainly in germ line cells, but...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S91295

    authors: Iliev R,Stanik M,Fedorko M,Poprach A,Vychytilova-Faltejskova P,Slaba K,Svoboda M,Fabian P,Pacik D,Dolezel J,Slaby O

    更新日期:2016-01-08 00:00:00

  • Effects of Huaier Extract on Ameliorating Colitis-Associated Colorectal Tumorigenesis in Mice.

    abstract:Background:Huaier extract has been a part of traditional Chinese medicine (TCM) for roughly 1600 years and may serve as a potential anti-cancer drug as it is associated with good efficacy and low toxicity. Individuals with inflammatory bowel disease (IBD) are at a higher chance of being diagnosed with colorectal cancer...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S253598

    authors: Zou YF,Rong YM,Chen ZX,Shen ZH,Chen X,Tan YX,Weng JR,Huang XM,Lin XT

    更新日期:2020-08-26 00:00:00

  • Association of TIMP-2-418G/C and TIMP-2-303G/A with gastric cancer: a meta-analysis.

    abstract:BACKGROUND:According to the relevant reports, TIMP-2 polymorphism might be associated with the susceptibility to gastric cancer. Owing to the inconclusive results from the published studies based on the association between TIMP-2 single nucleotide polymorphisms (SNPs) and gastric cancer susceptibility, a meta-analysis ...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S114113

    authors: Yang Y,Xiong Y,Li J,Wu C,Jiang J

    更新日期:2016-11-03 00:00:00

  • Molecular features of giant-cell carcinoma of the lung: a case report and literature review.

    abstract::Giant-cell carcinoma of the lung (GCCL) is a rare histological form of poorly differentiated non-small-cell lung cancer, which is classified as a subtype of pulmonary sarcomatoid carcinomas. In this case report, we describe the case of a 50-year-old Chinese male who presented with a pulmonary nodule in the right upper...

    journal_title:OncoTargets and therapy

    pub_type:

    doi:10.2147/OTT.S150124

    authors: Li X,Zhang Z,Liu J,Wang D,Wei S,Chen J

    更新日期:2018-02-09 00:00:00

  • Expression of Lin28 is correlated with prognosis and expression of HER-2 and steroid receptors in breast cancer.

    abstract:Objective:Cumulative data from clinical trials suggest that Lin28 may contribute to poor survival in breast cancer patients. The purpose of this study was to investigate the relationship between Lin28 expression and breast cancer patients' clinicopathological parameters. Methods:Data from a total of 291 breast cancer ...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S190328

    authors: Xu C,Jin S,Huang L

    更新日期:2019-02-08 00:00:00

  • Complete response with fluorouracil and irinotecan with a BRAFV600E and EGFR inhibitor in BRAF-mutated metastatic colorectal cancer: a case report.

    abstract:Background:Patients with BRAF (v-Raf murine sarcoma viral oncogene homolog B) V600E-mutated metastatic colorectal cancer (mCRC) have a poor prognosis. The Southwest Oncology Group (SWOG) 1406 study evaluated the efficacy of vemurafenib in combination with irinotecan and cetuximab for simultaneous inhibition of epiderma...

    journal_title:OncoTargets and therapy

    pub_type:

    doi:10.2147/OTT.S180845

    authors: Wang Z,Dai WP,Zang YS

    更新日期:2019-01-08 00:00:00

  • KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancer.

    abstract:Background:KIF18B was identified as a potential oncogene by analysis of The Cancer Genome Atlas database. Materials and methods:We assessed KIF18B expression and explored its clinical significance in cervical cancer tissues. We have also evaluated the effects of KIF18B on cervical cancer cell proliferation, migration,...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S157440

    authors: Wu Y,Wang A,Zhu B,Huang J,Lu E,Xu H,Xia W,Dong G,Jiang F,Xu L

    更新日期:2018-03-28 00:00:00

  • Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a retrospective study.

    abstract:Purpose:Bulky non-small cell lung cancer (NSCLC) is difficult to achieve effective local control by conventionally fractionated radiotherapy (CRT). The present work aims to evaluate the safety and efficacy of partial stereotactic ablative boost radiotherapy (P-SABR) in bulky NSCLC. Patients and methods:From December 2...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S159538

    authors: Bai Y,Gao XS,Qin SB,Chen JY,Su MM,Liu Q,Qin XB,Ma MW,Zhao B,Gu XB,Xie M,Cui M,Qi X,Li XY

    更新日期:2018-05-08 00:00:00

  • The associations between five polymorphisms of vascular endothelial growth factor and renal cell carcinoma risk: an updated meta-analysis.

    abstract:BACKGROUND:Vascular endothelial growth factor (VEGF) is a key mediator that plays an important role in angiogenesis, tumor growth, and tumor metastasis. The associations between five polymorphisms of VEGF (rs3025039, rs699947, rs10434, rs1570360, and rs2010963) and renal cell carcinoma (RCC) risk have been extensively ...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S125965

    authors: Wang J,Shen C,Fu Y,Yu T,Song J

    更新日期:2017-03-21 00:00:00

  • MicroRNA Profile Identifies miR-6165 Could Suppress Gastric Cancer Migration and Invasion by Targeting STRN4.

    abstract:Background:Recent studies showed that aberrant expression of miRNAs causes tumor-suppressing or promoting effects in various cancers including gastric cancer (GC). Our previous studies showed that lots of miRNAs and mRNA expressed differentially in GC and normal tissues. However, the critical miRNAs and mRNA need to be...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S208024

    authors: Wang Z,Li Y,Cao J,Zhang W,Wang Q,Zhang Z,Gao Z,Ye Y,Jiang K,Wang S

    更新日期:2020-03-03 00:00:00

  • Deleted in breast cancer 1 as a potential prognostic biomarker in human cancers: a pooled analysis of 2,254 patients.

    abstract:Background:Deleted in breast cancer 1 (DBC1) is believed to be involved in human cancers. However, it is still uncertain whether DBC1 expression can be regarded as a prognostic factor in patients with various cancers. This meta-analysis aimed to evaluate the relationship between high levels of DBC1 and prognosis in tum...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S189618

    authors: Liu G,Wu Q,Wang Y,Xiong Q,Fu F

    更新日期:2019-02-22 00:00:00

  • Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection.

    abstract:PURPOSE:This study sought to define the role of adjuvant radiation therapy (RT) for patients with curative intent resection of perihilar cholangiocarcinoma (pCCA). PATIENTS AND METHODS:By using the Surveillance, Epidemiology and End Results (SEER) registry, 1,917 patients with non-metastatic pCCA who underwent surgica...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S131873

    authors: Leng KM,Liu YP,Wang ZD,Zhong XY,Liao GQ,Kang PC,Cui YF,Jiang XM

    更新日期:2017-04-21 00:00:00

  • FLT3 inhibitors: clinical potential in acute myeloid leukemia.

    abstract::Acute myeloid leukemia (AML) is an aggressive hematopoietic malignancy that is cured in as few as 15%-40% of cases. Tremendous improvements in AML prognostication arose from a comprehensive analysis of leukemia cell genomes. Among normal karyotype AML cases, mutations in the FLT3 gene are the ones most commonly detect...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章,评审

    doi:10.2147/OTT.S103790

    authors: Hospital MA,Green AS,Maciel TT,Moura IC,Leung AY,Bouscary D,Tamburini J

    更新日期:2017-02-03 00:00:00

  • Identification of differentially expressed genes and signaling pathways in ovarian cancer by integrated bioinformatics analysis.

    abstract:Background:The mortality rate associated with ovarian cancer ranks the highest among gynecological malignancies. However, the cause and underlying molecular events of ovarian cancer are not clear. Here, we applied integrated bioinformatics to identify key pathogenic genes involved in ovarian cancer and reveal potential...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S152238

    authors: Yang X,Zhu S,Li L,Zhang L,Xian S,Wang Y,Cheng Y

    更新日期:2018-03-15 00:00:00

  • Development of an immunotherapeutic adenovirus targeting hormone-independent prostate cancer.

    abstract:BACKGROUND:To develop a targeting therapy for hormone-independent prostate cancer, we constructed and characterized conditionally replicating oncolytic adenovirus (Ad) equipped with mRFP (monomeric red fluorescence protein)/ttk (modified herpes simplex virus thymidine kinase). This construct was then further modified t...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S51749

    authors: Kim JS,Lee SD,Lee SJ,Chung MK

    更新日期:2013-11-12 00:00:00

  • Cyclin D1 affects epithelial-mesenchymal transition in epithelial ovarian cancer stem cell-like cells.

    abstract:BACKGROUND:The association of cancer stem cells with epithelial-mesenchymal transition (EMT) is receiving attention. We found in our previous study that EMT existed from CD24- phenotype cells to their differentiated cells. It was shown that cyclin D1 functioned in sustaining self-renewal independent of CDK4/CDK6 activa...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S44177

    authors: Jiao J,Huang L,Ye F,Shi M,Cheng X,Wang X,Hu D,Xie X,Lu W

    更新日期:2013-06-20 00:00:00

  • POEMS syndrome complicated with multiple ischemic vascular events: case report and review of literature.

    abstract::POEMS syndrome (acronym consisting of: polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes) is an uncommon disorder associated with an underlying plasma cell dyscrasia. There is no single specific test for POEMS, and due to its rarity and heterogeneity, patients are often mis- or underdiagnosed. ...

    journal_title:OncoTargets and therapy

    pub_type:

    doi:10.2147/OTT.S146221

    authors: Găman M,Vlădăreanu AM,Dobrea C,Onisâi M,Marinescu C,Cîşleanu D,Ciufu C,Vasile D,Bumbea H,Voican I

    更新日期:2018-09-27 00:00:00

  • LINC00680 Promotes the Progression of Non-Small Cell Lung Cancer and Functions as a Sponge of miR-410-3p to Enhance HMGB1 Expression.

    abstract:Purpose:LINC00680 was reported to be involved in various cancers through multiple mechanisms. Therefore, we intended to investigate its role in the progression of non-small cell lung cancer (NSCLC). Materials and Methods:Firstly, quantitative real-time polymerase chain reaction (qRT-PCR) was used to test LINC00680 in ...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S259232

    authors: Wang H,Feng L,Zheng Y,Li W,Liu L,Xie S,Zhou Y,Chen C,Cheng D

    更新日期:2020-08-18 00:00:00

  • The Protective Effect of Testosterone on the Ovarian Reserve During Cyclophosphamide Treatment.

    abstract:Introduction:Cyclophosphamide, which is widely used to treat malignant disease, causes ovarian follicular atresia, which leads to premature ovarian insufficiency. The present study evaluated the protective effect of testosterone in preventing the decline in the ovarian reserve during cyclophosphamide treatment. Method...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S242703

    authors: Yoo M,Tanaka T,Konishi H,Tanabe A,Taniguchi K,Komura K,Hayashi M,Ohmichi M

    更新日期:2020-04-08 00:00:00

  • A retrospective examination of the US Food and Drug Administration's clinical pharmacology reviews of oncology biologics for potential use of therapeutic drug monitoring.

    abstract:Background:Biologics have gained traction for use in oncology, but have demonstrate clinical variability for efficacy and safety. Therapeutic drug monitoring (TDM) can benefit patients' outcomes from a biologic therapy when the latter has a defined therapeutic window. A clinically relevant therapeutic window may exist ...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S153056

    authors: Fleisher B,Ait-Oudhia S

    更新日期:2017-12-27 00:00:00

  • Predictive value of single nucleotide polymorphisms in XRCC1 for radiation-induced normal tissue toxicity.

    abstract:Purpose:X-Ray Repair Cross Complementing 1 (XRCC1) functioning in the base excision repair pathway plays an important role in the repair of DNA single-strand breaks caused by ionizing radiation. The relationship between XRCC1 polymorphisms and the risk of radiation-induced side effects on normal tissues remains controv...

    journal_title:OncoTargets and therapy

    pub_type: 杂志文章

    doi:10.2147/OTT.S156175

    authors: Zhao J,Zhi Z,Zhang M,Li Q,Li J,Wang X,Ma C

    更新日期:2018-07-06 00:00:00

  • Activated pulmonary tuberculosis in a patient with melanoma during PD-1 inhibition: a case report.

    abstract:Background:PD-1 checkpoint inhibitors have shown a robust tumor response in the treatment of various cancers. Pembrolizumab is an anti-PD-1 checkpoint antibody approved for the treatment of unresectable or metastatic melanoma in more than 40 countries. Although autoimmune pneumonitis is considered a common immune-relat...

    journal_title:OncoTargets and therapy

    pub_type:

    doi:10.2147/OTT.S178246

    authors: He W,Zhang X,Li W,Kong C,Wang Y,Zhu L,Xu R,Deng G,Zhang P

    更新日期:2018-10-24 00:00:00